Biotekselskabet Pancryos fra København arbejder på en celleterapi, der skal kunne kurere type 1-diabetes. Folkene bag mener at have opdaget en fremgangsmåde, der kan overgå konkurrenterne på området. Read more...

For fem år siden sprang Jacqueline Ameri ud som iværksætter og takkede nej til egen forskergruppe. I dag er virksomheden netop blevet optaget i det prestigefyldte Creation House-program, hvor de har fået et lån på 10 mio. kr. fra Novo Nordisk Fonden. Read more...

The startup company PanCryos, which is a spinout from the Novo Nordisk Foundation Center for Stem Cell Biology at University of Copenhagen, receives a convertible loan of DKK 10 M. as well as entrepreneurial support from BioInnovation Institute, as they are enrolled...

The start-up PanCryos joins the Creation House program with a convertible loan of DKK 10M. Soon the company which is led by CEO and co-founder Dr. Jacqueline Ameri will move into BioInnovation Institute to continue the work on developing a new treatment for diabetes...

Stem cells are already being used in combating previously untreatable diseases. Nevertheless, stem cells are not delivering their full potential because the production of specific cell types from stem cells cannot yet be managed. Researchers have now...

People with type 1 diabetes strongly depend on injecting synthetically produced insulin. However, this situation may change within a few years. Today, researchers can already recreate insulin-producing beta cells from stem cells, which can be implanted in people with...

Scientists in Denmark say they’re one step closer to developing a stem-cell therapy that could eventually allow patients with type 1 diabetes (T1D) to be insulin independent again. Read more...

Researchers from Denmark are developing ways to make lab-grown insulin-producing cells safer. The future of type 1 diabetes treatment is likely to come from living cells that can produce and release insulin inside the person's body. In recent years, scientists have...